December 12, 2025

Hormonal Changes Influence Uveitis Activity

Reproductive life stages linked to distinct uveitis activity patterns across the female lifespan

The Ophthalmologist

December 11, 2025

Managing a Diabetic Foot Infection

A small ulcer hid a limb-threatening diabetic infection, highlighting how structured, guideline-based evaluation prevents missed diagnoses in high-risk patients.

Conexiant

December 10, 2025

This Week’s CGT News: Vertex’s Gene Therapies Show Promise in Younger Children

Our latest news roundup reports on new data for Vertex’s exa-cel, funding for a cell therapy for breast cancer, and new technologies for manufacturing

The Medicine Maker

December 01, 2025

WHO Issues Conditional GLP-1 Obesity Guideline

New recommendations emphasize equity barriers, health-system readiness, and the need for integrated chronic-disease management.

Conexiant

December 01, 2025

Three Keys to Closing the Communication Gap

New ACOG statement outlines relationship-centered strategies to build trust and improve outcomes, particularly for marginalized patients.

Conexiant

November 20, 2025

New study finds U.S. fluoride exposure linked to better adolescent cognitive performance 

A new study finds typical childhood fluoride exposure is linked to modestly better teen cognitive performance with no later cognitive harm.

ADA News

November 20, 2025

ADA urges Senate Finance Committee to include oral health in national health cost reforms 

The ADA outlined priorities for addressing cost drivers and improving oral health care access in a letter to the Senate Finance Committee.

ADA News

November 13, 2025

Transfusion Access Central to Hospice Decision-Making Among Patients With Blood Cancers

“Given that the majority of hospices in the United States do not provide transfusion access, patients with blood cancers are faced with the impossible choice of preserving access to palliative transfu...

The ASCO Post

November 12, 2025

This Week’s Biopharma News: Clinical Hold for Heart Disease Gene Therapy

Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly

The Medicine Maker